Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI)
为坦桑尼亚妇女提供预防艾滋病毒的选择并参与实施科学能力建设 (MWOTAJI)
基本信息
- 批准号:10749077
- 负责人:
- 金额:$ 125.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-18 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAdoptionAfricaAfrica South of the SaharaAgeAreaAwarenessBusinessesCaliforniaCaringClinicClinical ResearchCollaborationsCommunitiesContraceptive AgentsContraceptive methodsCost SharingCounselingCoupledDapivirineDataDevelopmentEnsureEnvironmentFaceFemale AdolescentsFriendsFutureGoalsGovernmentGrantHIVHIV InfectionsHealthHealth ServicesHealth care facilityHealth systemHouseholdIncentivesIncidenceInfectionInfrastructureInjectableKnowledgeLeadLocationMaintenanceModelingModernizationOralOutcomePharmaceutical PreparationsPharmacy facilityPilot ProjectsPoliciesPolicy MakerPopulationPrevention ResearchPrevention strategyPrivate SectorPrivatizationProspective cohortReach, Effectiveness, Adoption, Implementation, and MaintenanceRecordsReproductive Health ServicesResearchResearch PersonnelResourcesSan FranciscoServicesSexual HealthSexualitySiteSurveysTanzaniaTimeTrainingTraining ProgramsUniversitiesWomanYouthadolescent HIV preventioncertificate programcohortdesigneffectiveness outcomeeffectiveness studyeffectiveness/implementation studyempowermentepidemic responseevidence basegirlshigh-risk adolescentsimplementation evaluationimplementation frameworkimplementation outcomesimplementation researchimplementation scienceimplementation strategyinnovationperformance sitepillpre-exposure prophylaxisprogramspublic-private partnershiprandomized trialself testingsocial stigmasuccessunintended pregnancyuptakevulnerable adolescentyoung woman
项目摘要
SUMMARY
Adolescent girls and young women (AGYW; ages 15-24) in sub-Saharan Africa face a disproportionate burden
of HIV infection. Though highly effective HIV prevention like pre-exposure prophylaxis (PrEP) is central to the
global strategy for HIV epidemic control, awareness of PrEP among AGYW is low, with uptake and
continuation even lower—health systems are often ill equipped to overcome the numerous access barriers
faced by AGYW, including stigma, harmful norms, and the inconveniences of clinic-based health services.
There is growing recognition that community-based pharmacies have the potential to bridge gaps in HIV
prevention and mitigate access barriers among AGYW. Thus, the goal of this study is to evaluate the Malkia
Klabu (“Queen Club”) implementation strategy in Tanzania, a loyalty program designed for and by AGYW that
creates youth-friendly pharmacies where AGYW can access HIV prevention and sexual and reproductive
health (SRH) services, with strong linkages to facility-based care.
Based on promising data from our pilot study, we hypothesize that the creation of a welcoming and safe
pharmacy environment through the Malkia Klabu implementation model will attract AGYW and bolster uptake
of PrEP, HIV self-testing (HIVST), and other SRH services, thereby empowering AGYW to avoid HIV and
unintended pregnancy. We have designed an innovative, 5-year implementation science study to scale and
evaluate several models of Malkia Klabu’s pharmacy-based approach for PrEP and HIVST delivery in five
research sites in Lake Zone, Tanzania using the RE-AIM framework. This research will be enhanced by
implementation science training of local researchers and policymakers to optimize Malkia Klabu and benefit
future HIV prevention strategies. We will first conduct a Type 3 Hybrid Implementation-Effectiveness study of
four pharmacy-based differentiated PrEP delivery models of Malkia Klabu in 50 pharmacies, examining
implementation outcomes before and after the addition of user cost-sharing which is essential for real-world
sustainability (Aim 1). We will examine the success of the Malkia Klabu delivery models on effective use of
PrEP among a cohort of 575 AGYW, reach of the program in a cross-sectional household survey with 750
AGYW in study areas; pharmacy exit surveys with ~200 AGYW will help describe the success of pharmacy-
based PrEP service offerings (Aim 2). A Certificate in Implementation Science coupled with seed grants for
graduates will ensure the project has lasting impact (Aim 3).
At the study’s conclusion, we will determine the strongest and most sustainable version of the Malkia Klabu
implementation strategy for pharmacy-based PrEP and HIVST delivery to AGYW, and launched an
implementation science training program to enable locally-led scaling and adaptation to reach vulnerable
AGYW across Tanzania and the Region. The project is a collaboration between Mzumbe University, Health for
a Prosperous Nation, the Tanzania Ministry of Health, and University of California (San Francisco & Berkeley).
总结
撒哈拉以南非洲的少女和年轻妇女(15-24岁)面临着不成比例的负担
艾滋病毒感染。尽管像暴露前预防(PrEP)这样的高效艾滋病毒预防是预防艾滋病的核心,
艾滋病毒流行病控制全球战略,青年男女青年对PrEP的认识很低,
即使是较低级的卫生系统也往往装备不足,无法克服众多的准入障碍。
青年和女青年协会面临的各种挑战,包括耻辱、有害的规范和诊所保健服务的不便。
人们越来越认识到,社区药店有可能弥补艾滋病毒方面的差距
预防和减少青年女青年之间的准入障碍。因此,本研究的目的是评估Malkia
Klabu(“女王俱乐部”)在坦桑尼亚的实施战略,这是一个由AGYW设计并为之设计的忠诚度计划,
创建青年友好型药房,青年志愿者协会可在这些药房获得艾滋病毒预防以及性和生殖服务。
健康(SRH)服务,与基于设施的护理密切相关。
基于我们的试点研究的有希望的数据,我们假设,
通过Malkia Klabu实施模式的药房环境将吸引AGYW并加强吸收
预防性教育、艾滋病毒自我检测和其他性健康和生殖健康服务,从而使青年妇女协会有能力避免艾滋病毒,
意外怀孕我们设计了一项创新的、为期5年的实施科学研究,
评估Malkia Klabu基于药物的PrEP和HIVST交付方法的几种模型,
研究地点在坦桑尼亚湖区使用RE-AIM框架。这项研究将得到加强,
对当地研究人员和政策制定者进行实施科学培训,以优化Malkia Klabu,
未来的艾滋病毒预防战略。我们将首先进行第3类混合实施效果研究,
Malkia Klabu在50家药店的四种基于药店的差异化PrEP交付模式,
在增加用户分摊费用之前和之后的执行结果,
可持续性(目标1)。我们将研究Malkia Klabu交付模式在有效使用
PrEP在575名AGYW人群中的应用,该计划在一项横断面家庭调查中的覆盖率为750
研究领域的AGYW;约200 AGYW的药房退出调查将有助于描述药房的成功-
基于PrEP的服务提供(目标2)。实施科学证书加上种子赠款,
毕业生将确保该项目具有持久的影响(目标3)。
在研究结束时,我们将确定最强大和最可持续的Malkia Klabu版本
向AGYW提供基于药物的PrEP和HIVST的实施战略,并启动了
实施科学培训方案,使地方主导的扩大和适应工作能够惠及弱势群体
在坦桑尼亚和该地区的青年协会。该项目是Mzumbe大学,卫生和
一个繁荣的国家,坦桑尼亚卫生部和加州大学(旧金山弗朗西斯科和伯克利)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mackfallen Giliadi Anasel其他文献
Mackfallen Giliadi Anasel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 125.73万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 125.73万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 125.73万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 125.73万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 125.73万 - 项目类别:
Standard Grant